🇺🇸 Hydroxycobalamin in United States

44 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dizziness — 6 reports (13.64%)
  2. Vomiting — 6 reports (13.64%)
  3. Aggression — 5 reports (11.36%)
  4. Malaise — 5 reports (11.36%)
  5. Confusional State — 4 reports (9.09%)
  6. Dyspnoea — 4 reports (9.09%)
  7. Headache — 4 reports (9.09%)
  8. Hyperhidrosis — 4 reports (9.09%)
  9. Fatigue — 3 reports (6.82%)
  10. Libido Decreased — 3 reports (6.82%)

Source database →

Hydroxycobalamin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in United States

Frequently asked questions

Is Hydroxycobalamin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hydroxycobalamin in United States?

Christian Medical College, Vellore, India is the originator. The local marketing authorisation holder may differ — check the official source linked above.